Dow Up 0.00% Nasdaq Up 0.09%

Gilead Sciences Inc. (GILD)

-NasdaqGS
100.32 Up 0.02(0.02%) Nov 28, 1:00PM EST
Prev Close:100.30
Open:101.00
Bid:100.14 x 100
Ask:101.15 x 500
1y Target Est:122.63
Beta:1.24
Earnings Date:Feb 2 - Feb 6 (Est.)
Day's Range:99.70 - 101.33
52wk Range:63.50 - 116.83
Volume:7,552,697
Avg Vol (3m):15,456,600
Market Cap:151.35B
P/E (ttm):17.87
EPS (ttm):5.61
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDUp 0.02%151.35B
GSKDown 0.15%111.67B
PFEUp 0.16%196.27B
RHHBYUp 0.13%254.54B

Key Statistics

Forward P/E (1 yr):10.11
P/S (ttm):7.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :7.96
Quarterly EPS Est (Dec-14) :2.25
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.52

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback